GSK To Buy Added $940 Million Stake In India Consumer Healthcare Unit
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline said it plans to invest more than $1 billion in its India and Nigeria units to take advantage of two rapidly expanding markets.